Pregnancy outcomes following exposure to abatacept during pregnancy
Authors:
Open Access
- 1 December 2015
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 45 (3) , 351-356
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
This publication has 27 references indexed in Scilit:
- EditorialCurrent Opinion in Rheumatology, 2014
- Rheumatoid arthritis and pregnancyCurrent Opinion in Rheumatology, 2014
- Biologic therapies and pregnancy: the story so farRheumatology, 2013
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care & Research, 2012
- Unintended pregnancy in the United States: incidence and disparities, 2006Contraception, 2011
- Rheumatoid Arthritis and PregnancyDrugs, 2011
- Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useRheumatology, 2011
- Rheumatoid arthritis and pregnancy: Beyond smaller and preterm babiesArthritis & Rheumatism, 2010
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective studyArthritis & Rheumatism, 2009